Nedaplatin concurrent with three-dimensional conformal radiotherapy for treatment of locally advanced esophageal carcinoma

Table 1 Clinical data for patients in the nedaplatin group and the cisplatin group

	NDP group	DDP group	χ2	P value
Case	34	34
Gender
Male	18	20	0.239	0.625
Female	16	14
Age
Range	27-72	26-70
Median	54	53
Clinical stage (Union for International Cancer Control )
IIa	4	6	0.478	0.787
IIb	10	9
III	20	19
Tumor length
< 5 cm	14	17	0.534	0.465
≥ 5 cm	20	17
Cervical	5	3
Location in the esophagus
Upper	12	15	1.130	0.770
Middle	14	12
Lower	3	4
Medullary	20	22
Fungoid	6	5
Pathology
Ulcer type	5	5	0.386	0.943
Sclerotic type	3	2
General status (Eastern Cooperative Oncology Group score)
0-1	24	21	0.591	0.442
2	10	13

NDP: Nedaplatin; DDP: Cisplatin.